Interim Report Quarter 2, 2026

Q2 2026 net sales rose 2.6% to SEK 35,061m, but profitability softened: EBITA fell to SEK 4,105m from SEK 4,628m and the EBITA margin (excl. IAC) declined 0.3pp to 13.4%. ROCE dropped to 14.0% (from 16.7%) and profit for the period decreased to SEK 2,693m (from SEK 3,053m), with EPS falling to SEK 3.94 (from SEK 4.39). Overall, results show resilient revenue but weaker margins/returns in a volatile external environment.

Analysis

The key read-through is not the modest top-line growth; it is that volume is doing the work while price/mix is still negative. That usually signals either competitive discounting or a product/customer mix shift toward lower-margin business, which is fine for share capture only if it does not become the new baseline. When EBITA ex one-offs is essentially flat despite unit growth, the market should assume leverage is being surrendered to defend volume — a setup that often compresses valuation multiples for premium operators if peers are forced to follow with lower prices.

Second-order effects are more interesting than the headline: suppliers tied to this demand chain may see stable shipments but weaker realized pricing, while smaller competitors with less scale are likely to feel the margin pinch first. If this is a consumer- or industrial-facing franchise, the pressure can ripple into distributors and private-label alternatives as customers use the weak pricing backdrop to renegotiate. That tends to favor the cheapest substitute in the channel over the branded incumbent, especially over the next 1-3 quarters.

The contrarian view is that this may be a near-term margin reset rather than a demand deterioration story. If cost inflation keeps cooling, negative price/mix can coexist with stable EBITA for a few more quarters, and the market may be over-penalizing a company that is protecting volume in a soft end-market. The thesis breaks if next quarter shows price/mix moving back toward flat and EBITA margin holds above the current run rate; if not, this becomes a longer-duration multiple compression story over 6-18 months.

Key Decisions for Investors

• If a sector proxy exists, favor a pair trade: long the higher-quality, lower-pricing-pressure incumbent vs. short the more levered peer set that depends on price to defend volume. Time horizon: 1-3 months; target 5-10% relative outperformance if industry pricing stays soft.
• Use XLP or IYK as a defensive long only if the company sits in consumer staples/discretionary supply chains; the read-through is that private-label and value-oriented channels gain share when branded pricing turns negative. Risk: if pricing normalizes next quarter, the trade should be cut.
• Avoid chasing the stock on the reported volume beat. Wait for the next quarterly print or management commentary confirming whether price/mix remains negative; that is the real catalyst. Falsifier: price/mix turns flat-to-positive and margin re-expands by ~50 bps.
• For a tactical hedge, short the most margin-sensitive competitor basket in the same end-market on any rally over the next 2-4 weeks. The setup is best if peers also report volume strength with weak pricing, which would validate an industry-wide discounting cycle.
• Watch for a 6-18 month rerating only if ROCE stabilizes and EBITA margin stops drifting lower. If that does not happen, treat this as a quality trap and rotate toward businesses with structurally better pricing power rather than adding on dips.